SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-129882
Filing Date
2022-12-23
Accepted
2022-12-23 16:03:33
Documents
19
Period of Report
2022-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2233312d2_8k.htm   iXBRL 8-K 33850
2 EXHIBIT 4.1 tm2233312d2_ex4-1.htm EX-4.1 116502
3 EXHIBIT 5.1 tm2233312d2_ex5-1.htm EX-5.1 9069
4 EXHIBIT 10.1 tm2233312d2_ex10-1.htm EX-10.1 187451
5 EXHIBIT 10.2 tm2233312d2_ex10-2.htm EX-10.2 58531
6 EXHIBIT 99.1 tm2233312d2_ex99-1.htm EX-99.1 11368
10 GRAPHIC tm2233312d2_ex5-1img001.jpg GRAPHIC 3163
11 GRAPHIC tm2233312d2_ex99-1img001.jpg GRAPHIC 5044
  Complete submission text file 0001104659-22-129882.txt   706586

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA otlk-20221223.xsd EX-101.SCH 3322
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE otlk-20221223_lab.xml EX-101.LAB 34986
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE otlk-20221223_pre.xml EX-101.PRE 22617
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2233312d2_8k_htm.xml XML 3695
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 221485379
SIC: 2836 Biological Products, (No Diagnostic Substances)